Inovio Pharmaceuticals In...

NASDAQ: INO · Real-Time Price · USD
1.85
0.23 (14.20%)
At close: Aug 15, 2025, 3:00 PM

Inovio Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
65.81M 14.31M 46.33M 71.14M
Short-Term Investments
28.3M 130.98M 206.67M 330.17M
Long-Term Investments
1.61M 2.78M 2.01M 3.91M
Other Long-Term Assets
3.68M 605.32K 684.04K 1.43M
Receivables
1.2M 2.41M 11.74M 8.03M
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 20.43K 30.38M 261.19K
Total Current Assets
97.83M 153.11M 315.24M 448.44M
Property-Plant & Equipment
11.77M 14.45M 17.96M 29.02M
Goodwill & Intangibles
n/a n/a 12.64M 13.14M
Total Long-Term Assets
17.07M 17.84M 33.29M 47.5M
Total Assets
113.2M 170.95M 348.53M 495.94M
Account Payables
6.44M 4.65M 21.08M 27.97M
Deferred Revenue
n/a n/a n/a 21.63K
Short-Term Debt
2.5M 16.77M 2.8M 2.6M
Other Current Liabilities
23.89M 9.95M 12.33M 18.11M
Total Current Liabilities
35.33M 42.57M 96.87M 65.74M
Long-Term Debt
n/a n/a 16.61M 14.96M
Other Long-Term Liabilities
n/a n/a -16.61M 14.83K
Total Long-Term Liabilities
9.37M 11.03M 29.3M 30.53M
Total Liabilities
44.69M 53.6M 126.17M 96.27M
Total Debt
11.87M 30.21M 32.07M 33.02M
Common Stock
36.1K 22.79K 253.09K 217.38K
Retained Earnings
-1.73B -1.62B -1.49B -1.21B
Comprehensive Income
-675.67K -662.6K -698.74K -282.24K
Shareholders Equity
68.5M 117.35M 222.36M 399.67M
Total Investments
29.91M 133.76M 208.68M 334.08M